A Phase II Trial of Combination Therapy With Thalidomide and CPT-11 in Patients With Recurrent Anaplastic Gliomas or Glioblastoma Multiforme.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2012
At a glance
- Drugs Irinotecan; Thalidomide
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- 13 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Feb 2006 New trial record.